HU215519B - Eljárás N-metil-3-fenil-3-(2-metiltio-fenoxi)-propil-amin és az ezt tartalmazó gyógyszerkészítmények előállítására - Google Patents

Eljárás N-metil-3-fenil-3-(2-metiltio-fenoxi)-propil-amin és az ezt tartalmazó gyógyszerkészítmények előállítására Download PDF

Info

Publication number
HU215519B
HU215519B HU9203051A HU9203051A HU215519B HU 215519 B HU215519 B HU 215519B HU 9203051 A HU9203051 A HU 9203051A HU 9203051 A HU9203051 A HU 9203051A HU 215519 B HU215519 B HU 215519B
Authority
HU
Hungary
Prior art keywords
formula
preparation
phenyl
compound
pharmaceutically acceptable
Prior art date
Application number
HU9203051A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT65375A (en
HU9203051D0 (en
Inventor
Donald Richard Gehlert
David Wayne Robertson
David Taiwai Wong
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HU9203051D0 publication Critical patent/HU9203051D0/hu
Publication of HUT65375A publication Critical patent/HUT65375A/hu
Publication of HU215519B publication Critical patent/HU215519B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/29—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU9203051A 1991-09-27 1992-09-24 Eljárás N-metil-3-fenil-3-(2-metiltio-fenoxi)-propil-amin és az ezt tartalmazó gyógyszerkészítmények előállítására HU215519B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/766,993 US5281624A (en) 1991-09-27 1991-09-27 N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof

Publications (3)

Publication Number Publication Date
HU9203051D0 HU9203051D0 (en) 1992-12-28
HUT65375A HUT65375A (en) 1994-05-02
HU215519B true HU215519B (hu) 1999-01-28

Family

ID=25078150

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9203051A HU215519B (hu) 1991-09-27 1992-09-24 Eljárás N-metil-3-fenil-3-(2-metiltio-fenoxi)-propil-amin és az ezt tartalmazó gyógyszerkészítmények előállítására

Country Status (23)

Country Link
US (1) US5281624A (en, 2012)
EP (1) EP0534756A3 (en, 2012)
JP (2) JPH05238996A (en, 2012)
KR (1) KR100221180B1 (en, 2012)
CN (1) CN1033580C (en, 2012)
AT (1) ATE124934T1 (en, 2012)
AU (1) AU655075B2 (en, 2012)
BR (2) BR9203743A (en, 2012)
CA (2) CA2079161C (en, 2012)
CZ (1) CZ281817B6 (en, 2012)
DE (1) DE69203424T2 (en, 2012)
FI (1) FI111250B (en, 2012)
HU (1) HU215519B (en, 2012)
IL (1) IL103277A (en, 2012)
MX (1) MX9205433A (en, 2012)
MY (1) MY108304A (en, 2012)
NO (1) NO178109C (en, 2012)
NZ (1) NZ244460A (en, 2012)
RU (1) RU2057120C1 (en, 2012)
SK (1) SK290892A3 (en, 2012)
TW (1) TW249225B (en, 2012)
YU (1) YU87192A (en, 2012)
ZA (1) ZA927240B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720320B2 (en) * 1999-05-24 2004-04-13 Mitsubishi Pharma Corporation Phenoxypropylamine compounds

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087765B2 (en) * 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
EA000856B1 (ru) * 1995-07-24 2000-06-26 Эли Лилли Энд Компани Способ лечения синдрома дефицита внимания/гиперактивности
CA2266070A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
US6586427B2 (en) 1998-04-09 2003-07-01 Pharmacia & Upjohn Company Treatments for nervous disorders
DE69926616T2 (de) * 1998-04-09 2006-05-24 Pharmacia & Upjohn Co. Llc, Kalamazoo Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
EP1466889B1 (en) * 1999-04-06 2008-06-04 Sepracor Inc. O-Desmethylvenlafaxine succinate
DE60035232T2 (de) 1999-07-01 2008-02-14 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom
US20040034106A1 (en) * 2001-11-06 2004-02-19 Read Holly Ann Treatment of anxiety disorders
PT1455770E (pt) * 2001-11-30 2007-09-06 Lilly Co Eli Uso de inibidores de reabsorção da norepinefrina para o tratamento dos transtornos de tiques.
US20050009925A1 (en) * 2001-12-11 2005-01-13 Bymaster Franklin Porter Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
US6846823B2 (en) * 2003-04-04 2005-01-25 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
CA2536161A1 (en) * 2003-08-27 2005-03-10 Eli Lilly And Company Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors
JP2007513945A (ja) * 2003-12-12 2007-05-31 イーライ リリー アンド カンパニー 体熱感、衝動調節障害および一般的な病状による人格変化の治療
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.
WO2019076904A1 (en) * 2017-10-16 2019-04-25 Esteve Pharmaceuticals, S.A. PROPANAMINE DERIVATIVES FOR THE TREATMENT OF PAIN AND PAIN DISEASES ASSOCIATED WITH PAIN
CN113121394B (zh) * 2019-12-30 2022-11-08 中国药科大学 一种苯氧乙酸类衍生物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4313896A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Aryloxyphenylpropylamines
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4584404A (en) * 1974-01-10 1986-04-22 Eli Lilly And Company Substituted phenoxyphenylproply dimethylamines
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
IL89854A (en) * 1988-04-08 1994-02-27 Lilly Co Eli Phenoxypropanamines, the process for their preparation and medicinal preparations containing them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720320B2 (en) * 1999-05-24 2004-04-13 Mitsubishi Pharma Corporation Phenoxypropylamine compounds
US7196199B2 (en) 1999-05-24 2007-03-27 Mitsubishi Pharma Corporation Phenoxypropylamine compounds

Also Published As

Publication number Publication date
SK280480B6 (sk) 2000-02-14
HUT65375A (en) 1994-05-02
JP3256291B2 (ja) 2002-02-12
FI111250B (fi) 2003-06-30
CN1071416A (zh) 1993-04-28
CN1033580C (zh) 1996-12-18
NO923710D0 (no) 1992-09-24
NZ244460A (en) 1994-10-26
CZ281817B6 (cs) 1997-02-12
CZ290892A3 (en) 1993-04-14
EP0534756A3 (en) 1993-06-16
FI924305L (fi) 1993-03-28
HU9203051D0 (en) 1992-12-28
DE69203424D1 (de) 1995-08-17
NO178109C (no) 1996-01-24
US5281624A (en) 1994-01-25
IL103277A (en) 1997-11-20
JPH05201961A (ja) 1993-08-10
BR1100384A (pt) 1999-08-31
NO178109B (no) 1995-10-16
JPH05238996A (ja) 1993-09-17
IL103277A0 (en) 1993-02-21
CA2079161C (en) 2004-02-17
MY108304A (en) 1996-09-30
KR100221180B1 (ko) 1999-09-15
RU2057120C1 (ru) 1996-03-27
EP0534756A2 (en) 1993-03-31
YU87192A (sh) 1995-10-24
KR930005972A (ko) 1993-04-20
CA2079162A1 (en) 1993-03-28
CA2079161A1 (en) 1993-03-28
MX9205433A (es) 1993-03-01
FI924305A0 (fi) 1992-09-25
SK290892A3 (en) 2000-02-14
TW249225B (en, 2012) 1995-06-11
AU2537092A (en) 1993-04-01
DE69203424T2 (de) 1996-01-11
ATE124934T1 (de) 1995-07-15
AU655075B2 (en) 1994-12-01
BR9203743A (pt) 1993-04-20
NO923710L (no) 1993-03-29
ZA927240B (en) 1994-03-22

Similar Documents

Publication Publication Date Title
HU215519B (hu) Eljárás N-metil-3-fenil-3-(2-metiltio-fenoxi)-propil-amin és az ezt tartalmazó gyógyszerkészítmények előállítására
DE69733432T2 (de) N-(aryl/heteroaryl/alkylacetyl) amino saüre amide, pharmazeutische zusammensetzungen damit, und methodenzur inhibierung beta-amyloid peptid freisetzung oder synthese
HUP0300832A2 (hu) Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
CA2071897A1 (en) Sigma receptor ligands and the use thereof
KR102487051B1 (ko) 아미노카보닐카바메이트 화합물
US5055468A (en) Use of bridged tricyclic amine derivatives as anti-ischemic agents
HU190887B (en) Process for the preparation of 2-pehnyl-methylen-cycloalkyl-amines and azetidines
US20040235922A1 (en) Compositions and methods for inducing adipose tissue cell death
KR19990044675A (ko) 디아릴알케닐아민 유도체
AU749643B2 (en) Method for treating protozoal infections
JP4541879B2 (ja) ケイ皮酸二量体、その製造方法及び退行性脳疾患治療のためのその用途
EP0537915B1 (en) N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines as norepinephrine inhibitors
DE3879402T2 (de) Selektive sertonin-aufnahme-inhibitoren.
EP4582412A1 (en) Chiral gamma lactam derivative or pharmaceutically acceptable salt thereof, and preparation method therefor
JP3681770B2 (ja) 老年性痴呆症又はアルツハイマー病治療剤
US6114381A (en) Non-heterocyclic β-phenyl-α-aminopropionic acid n-phenyl amides for treatment of neurotoxic injury
US3218232A (en) Method for relieving depression and composition therefor
US5192762A (en) Use of bridged tricyclic amine derivatives as anti-ischemic agents
JP2011506352A (ja) ４−［２，３−ジフルオロ−６−（２−フルオロ−４−メチル−フェニルスルファニル）−フェニル］−ピペリジン
DE2227842C3 (de) Diphenylcyclopentane und diese enthaltende Arzneimittel
US6242466B1 (en) Substituted phenylamidines
JPH093039A (ja) ドーパミン再取込みを阻害するための（α−アミノメチル−３，４−ジクロロベンジル）チオアセトアミド誘導体の使用およびこの使用のための新規化合物
EP0591581A1 (en) N-Alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines
EP0518216A2 (en) N-/Arylethyl/-N-alkyl-2-(1-pyrrolidinyl)ethylamine derivatives for CNS disorders
WO1999020278A1 (en) Use of moxonidine for the treatment of depression

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee